Generium is the leading Russian biopharmaceutical company, focused on developing and commercializing diagnostic systems and pharmaceutical products for the treatment of orphan diseases, infection diseases, cancer, multiple sclerosis, myocardial infarction and strokes. Generium consists of a high-end R&D center and a fully integrated manufacturing plant. Generium has more than 30 innovative products in the pipeline, including enzymes, monoclonal antibodies and ATMPs. Generium is headquartered in Moscow, Russia.
| Website | http://www.generium.ru |
| Revenue | $6.6 million |
| Employees | 1 (1 on RocketReach) |
| Address | 2 Testovskaya St, Moscow, Moscow 123112, RU |
| Phone | +7 495 988-47-94 |
| Industry | Manufacturing General, Biotechnology, Manufacturing, Science and Engineering |
| Competitors | Boehringer Ingelheim, Teva Pharmaceuticals, Sandoz, Glenmark Pharmaceuticals, Valeant Pharmaceuticals, JSC BIOCAD, R-Pharm, Sintez Technologies Limited, MSD, AstraZeneca Russia +23 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Generium employee's phone or email?
Generium Questions
The Generium annual revenue was $6.6 million in 2026.
1 people are employed at Generium.
Generium is based in Moscow, Moscow.
The NAICS codes for Generium are [32, 325, 32541, 3254].
The SIC codes for Generium are [28, 283].
Top Generium Employees
